Life Science

Rituximab (Rituxan) is a humanized monoclonal antibody that is approved by the U.S.

Rituximab (Rituxan) is a humanized monoclonal antibody that is approved by the U.S.

Rituximab (Rituxan) is a humanized monoclonal antibody that is approved by the U.S.

Rituximab (Rituxan) is a humanized monoclonal antibody that is approved by the U.S.

Tocilizumab also known as atlizumab, is a humanized monoclonal antibody that is approved by the U.S.

Tocilizumab also known as atlizumab, is a humanized monoclonal antibody that is approved by the U.S.

Tocilizumab also known as atlizumab, is a humanized monoclonal antibody that is approved by the U.S.

Tocilizumab (Actemra) is a humanized monoclonal antibody that is developed by Hoffmann–La Roche and Chugai for the trea&tradeent of patients with rheumatoid arthritis (RA) and systemic juvenile idiopathic arthritis, a severe form of arthritis in

A synthetic hexapeptide with an acetylated amino terminus and an amidated carboxyl terminus that inhibits the binding of CXC chemokines to the chemokine receptor CXCR2 inhibits IL-8 binding to neutrophils (Ki = 2.7-13 &microM), prevents neutrophil

A synthetic hexapeptide with an acetylated amino terminus and an amidated carboxyl terminus that inhibits the binding of CXC chemokines to the chemokine receptor CXCR2 inhibits IL-8 binding to neutrophils (Ki = 2.7-13 &microM), prevents neutrophil

A synthetic hexapeptide with an acetylated amino terminus and an amidated carboxyl terminus that inhibits the binding of CXC chemokines to the chemokine receptor CXCR2 inhibits IL-8 binding to neutrophils (Ki = 2.7-13 &microM), prevents neutrophil

An antibiotic that inhibits complex III of the mitochondrial ETC, preventing electron transport between cytochromes b and c, which results in the production of superoxide and eventual cell death inhibits Bcl-2 and Bcl-xL proteins, inducing